[Neuroleptic malignant-like syndrome following levodopa withdrawal].
The description of a syndrome similar to the neuroleptic malignant syndrome but occurring after levodopa withdrawal in a parkinsonian patient is reported. The imputation of levodopa withdrawal is analyzed according to the method of assessment of unexpected drug reactions used by the French centers of pharmacovigilance. This case is compared to 8 other published ones.
Rascol
O
O
Service de Pharmacologie Médicale et Clinique, INSERM U317, Toulouse.
Salachas
F
F
Montastruc
J L
JL
D000368:Aged; D006801:Humans; D007980:Levodopa / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy*; D010300:Parkinson Disease / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome
D007980:Levodopa
Syndrome malin analogue à celui des neuroleptiques après arrêt de la levodopa.